MENU
+Compare
CSTL
Stock ticker: NASDAQ
AS OF
Sep 16 closing price
Price
$21.75
Change
+$0.13 (+0.60%)
Capitalization
630.93M

CSTL Castle Biosciences Forecast, Technical & Fundamental Analysis

Castle Biosciences Inc is a molecular diagnostics company... Show more

CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CSTL with price predictions
Sep 16, 2025

Aroon Indicator for CSTL shows an upward move is likely

CSTL's Aroon Indicator triggered a bullish signal on September 16, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 180 similar instances where the Aroon Indicator showed a similar pattern. In of the 180 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for CSTL crossed bullishly above the 50-day moving average on August 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CSTL moved out of overbought territory on September 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CSTL as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on September 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CSTL broke above its upper Bollinger Band on August 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.385) is normal, around the industry mean (9.935). P/E Ratio (30.242) is within average values for comparable stocks, (137.541). CSTL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.697). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (1.845) is also within normal values, averaging (9.413).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CSTL is expected to report earnings to fall 469.60% to -55 cents per share on November 10

Castle Biosciences CSTL Stock Earnings Reports
Q3'25
Est.
$-0.55
Q2'25
Beat
by $0.66
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.08
The last earnings report on August 04 showed earnings per share of 15 cents, beating the estimate of -50 cents. With 435.22K shares outstanding, the current market capitalization sits at 630.93M.
A.I. Advisor
published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TICSX7.430.01
+0.13%
Touchstone Small Company Instl
TMCJX49.78N/A
N/A
Touchstone Mid Cap C
ENHNX10.47N/A
N/A
Cullen Enhanced Equity Income I
TNXAX10.77N/A
N/A
1290 Loomis Sayles Multi-Asset Income A
BTIRX178.16N/A
N/A
DWS Equity 500 Index R6

CSTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+0.60%
TCMD - CSTL
50%
Loosely correlated
+2.07%
NTRA - CSTL
40%
Loosely correlated
+1.66%
FLGT - CSTL
38%
Loosely correlated
-0.18%
OFIX - CSTL
38%
Loosely correlated
+0.61%
GH - CSTL
37%
Loosely correlated
+1.11%
More